论文部分内容阅读
目的观察沙丁胺醇联合布地奈德雾化吸入治疗小儿支气管哮喘急性发作的临床疗效。方法将120例支气管哮喘急性发作的患儿作为观察组,另选取同期患儿40例作为对照组,两组均采用常规对症治疗的基础上,对照组单纯采用沙丁胺醇雾化吸入,观察组使用布地奈德联合沙丁胺醇雾化吸入,观察治疗效果。结果实验中对照组与观察组的总的有效率分别为42.5%、85.8%,二者差异有统计学意义;观察组有出现口咽部刺激感3例,对症处理后症状消失。结论布地奈德联合沙丁胺醇雾化吸入治疗小儿支气管哮喘,疗效高,全身副作用小,症状缓解迅速,副反应少,值得临床推广。
Objective To observe the clinical efficacy of salbutamol combined with budesonide inhalation in the treatment of children with acute attack of bronchial asthma. Methods A total of 120 children with acute bronchial asthma were selected as the observation group and 40 children in the same period were selected as the control group. Both groups were treated with conventional symptomatic treatment. The control group was treated with salbutamol inhalation alone. The observation group was given budesonide Ned combined inhalation of salbutamol inhalation to observe the therapeutic effect. Results The total effective rates of the control group and the observation group were 42.5% and 85.8%, respectively, with significant difference between the two groups. In the observation group, there were 3 cases of oropharyngeal irritation, and symptoms disappeared after symptomatic treatment. Conclusion Budesonide inhalation combined with salbutamol inhalation in children with bronchial asthma, high efficacy, systemic side effects, rapid response, side effects, worthy of clinical promotion.